Page 3 - Diabetes

Pharma market grows 8.7% in August; cardiac and anti-diabetic segments lead

The Indian Pharma Market grew 8.7% in August 2025, with the cardiac, anti-diabetic, and anti-neoplastic segments driving growth. Sun Pharma maintained its leadership position

Nocturia: Understanding night-time urination, causes and its solutions

Frequent urination at night is common but not always harmless. Doctors highlight the risks, underlying causes, and practical steps you can take to improve sleep and protect your health

Why it's harder to burn fat with age, and how scientists plan to fix it

Ageing slows our body's natural calorie burners, but a new study shows how reactivating beige fat could help tackle weight gain, diabetes, and heart disease

Will this court fight make the world's hottest weight-loss drug cheaper?

Indian pharma takes Novo Nordisk to court over patents that keep Wegovy and Ozempic out of reach - could this slash prices for millions of patients?

Why men are more likely to die from diabetes, hypertension and HIV

A global study in PLOS Medicine shows men have higher death rates from diabetes, hypertension and HIV/AIDS, largely due to risky lifestyles and lower healthcare use

Eating French fries often raises diabetes risk, Harvard study warns

A study tracking 200,000 US adults reveals eating French fries three times a week can increase type 2 diabetes risk by 20% while boiled or baked potatoes show no such link when eaten in moderation

Ozempic, other weight-loss drugs tied to rare, serious eye issue: Study

Non-arteritic anterior ischaemic optic neuropathy, or NAION, is a rare but devastating eye condition that occurs when blood flow to the optic nerve is suddenly reduced or blocked

Inflammation control in diabetics may cure depression, methods vary: Study

An analysis has revealed that addressing inflammation in diabetes can help determine success in treating depression in a group of patients. However, there are differences in outcomes between type 1 and type 2 diabetes, researchers said. While type 2 diabetes is a metabolic condition marked by an inability to manage blood sugar, type 1 diabetes is an autoimmune disorder in which the body's immune system mistakenly attacks and damages insulin-producing cells in the pancreas. "People with type 2 diabetes and high inflammation levels possibly respond particularly well to a change in depressive cognitions through cognitive behavioural therapy. People with type 1 diabetes and high inflammation levels, on the other hand, could benefit more from anti-inflammatory drug therapies," said author Norbert Hermanns from the Research Institute of the Diabetes Academy Mergentheim (FIDAM), Germany. Findings published in the journal Diabetologia could help develop customised treatment plans for ...

One-fifth of Indians aged 45 and above had diabetes in 2019: Study

About a fifth of those aged 45 and above were living with diabetes in 2019, with two in every five possibly unaware of their condition, according to data from a study among India's ageing adults. Findings published in The Lancet Global Health also suggest that as the country's population rapidly ages, diabetes cases among the middle-aged and older adults will increase, even if increase in prevalence of the condition in age-specific groups can be arrested, authors said. Researchers, including those from the International Institute for Population Sciences, Mumbai, and US, also found that 46 per cent of those aware of their diabetes regained a control over blood sugar levels, while around 60 per cent were able to control their blood pressure the same year. Six per cent were taking a lipid-lowering medication to reduce the risk of cardiovascular disease, the team said. The 'Longitudinal Aging Study in India' (LASI), which surveyed about 60,000 adults aged 45 and above during 2017-2019

Weighty issues: India's rush to make weight-loss drugs demands user caution

The global market for weight-loss drugs is estimated at $100 billion by the end of the decade

7,000 steps a day - that's all it takes to outwalk heart disease, says study

A global study finds that walking 7,000 steps daily can significantly reduce the risk of death by heart disease, diabetes, dementia and more, offering a practical alternative to the 10,000-step target

Biocon Biologics expands diabetes portfolio with FDA approval for Kirsty

Interchangeable biosimilar to NovoLog in the US and will be available in prefilled pens and vials

From blood pressure to mental health, key health checks men must not skip

From blood pressure to mental health, these essential screenings help men detect silent health risks early and stay ahead of preventable chronic conditions

Muscle loss to cancer: Shubhanshu Shukla's mission targets health in space

Indian astronaut Shubhanshu Shukla is leading muscle loss, diabetes, brain activity, and cancer cell studies on the ISS-research that could benefit both space explorers and patients on Earth

Diabetes myths vs facts: 15 health risks you may be unknowingly taking

Fact-Check Friday: From the belief that fruits are bad to blaming sugar alone, doctors bust 15 widespread diabetes myths and offer clear, science-backed facts for better care

Why jamun seed powder is called a superfood for managing diabetes

Jamun seed powder contains jamboline and jambosine that help regulate blood sugar, support pancreatic function, and may aid in diabetes prevention if used correctly

Understanding gestational diabetes: Why early detection, awareness matter

Despite common misconceptions, gestational diabetes can affect healthy women of any age or body type. Often symptomless, it frequently goes undiagnosed-putting both mother and child at risk

Does your job involve meeting people? It may raise diabetes risk: Study

A 14-year study of nearly 3 million people found that emotional strain in public-facing roles may increase type 2 diabetes risk by up to 47 per cent

Stem cell breakthrough: New therapy raises hopes of curing type 1 diabetes

A new stem cell-based treatment helped most trial participants with severe type 1 diabetes stop insulin use, offering hope for long-term freedom from injections

Abbott, MSD join hands to distribute key diabetic drug across India

Abbott to distribute MSD's sitagliptin portfolio-Januvia, Janumet, Janumet XR-in India, targeting deeper reach in the ₹950-1,000 crore diabetes drug segment